These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16767175)

  • 1. Mutant alpha-synuclein-induced degeneration is reduced by parkin in a fly model of Parkinson's disease.
    Haywood AF; Staveley BE
    Genome; 2006 May; 49(5):505-10. PubMed ID: 16767175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
    Haywood AF; Staveley BE
    BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease.
    Todd AM; Staveley BE
    Genome; 2008 Dec; 51(12):1040-6. PubMed ID: 19088817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila.
    M'Angale PG; Staveley BE
    BMC Neurosci; 2016 May; 17(1):24. PubMed ID: 27192974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
    Lo Bianco C; Schneider BL; Bauer M; Sajadi A; Brice A; Iwatsubo T; Aebischer P
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17510-5. PubMed ID: 15576511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila.
    Yang Y; Nishimura I; Imai Y; Takahashi R; Lu B
    Neuron; 2003 Mar; 37(6):911-24. PubMed ID: 12670421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
    Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
    J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease.
    Botella JA; Bayersdorfer F; Schneuwly S
    Neurobiol Dis; 2008 Apr; 30(1):65-73. PubMed ID: 18243716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saffron ameliorated motor symptoms, short life span and retinal degeneration in Parkinson's disease fly models.
    Inoue E; Suzuki T; Shimizu Y; Sudo K; Kawasaki H; Ishida N
    Gene; 2021 Oct; 799():145811. PubMed ID: 34224829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Animal models for familial Parkinson's disease].
    Takahashi R
    Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of dopaminergic neuronal dysfunction in genetic and toxin-induced models of Parkinson's disease in Drosophila.
    Navarro JA; Heßner S; Yenisetti SC; Bayersdorfer F; Zhang L; Voigt A; Schneuwly S; Botella JA
    J Neurochem; 2014 Nov; 131(3):369-82. PubMed ID: 25040725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation.
    Du G; Liu X; Chen X; Song M; Yan Y; Jiao R; Wang CC
    Mol Biol Cell; 2010 Jul; 21(13):2128-37. PubMed ID: 20444973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson's disease.
    Yamada M; Mizuno Y; Mochizuki H
    Hum Gene Ther; 2005 Feb; 16(2):262-70. PubMed ID: 15761265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Drosophila model of Parkinson's disease.
    Feany MB; Bender WW
    Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
    Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures.
    Park SS; Lee D
    Eur J Neurosci; 2006 Jun; 23(11):2908-14. PubMed ID: 16819979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson's disease phenotypes.
    Julienne H; Buhl E; Leslie DS; Hodge JJL
    Neurobiol Dis; 2017 Aug; 104():15-23. PubMed ID: 28435104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease.
    Trinh K; Moore K; Wes PD; Muchowski PJ; Dey J; Andrews L; Pallanck LJ
    J Neurosci; 2008 Jan; 28(2):465-72. PubMed ID: 18184789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.